- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sumitomo Dainippon Pharma Co Ltd (4506)
Sumitomo Dainippon Pharma Co Ltd stock price live, this page displays TYO 4506 stock exchange data. View the 4506 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sumitomo Dainippon Pharma Co Ltd real time stock price chart below.
What Is the Sumitomo Dainippon Pharma Co Ltd Stock Price Today?
The Sumitomo Dainippon Pharma Co Ltd stock price today is 2,192.0.
What Is the Stock Symbol for Sumitomo Dainippon Pharma Co Ltd?
The stock ticker symbol for Sumitomo Dainippon Pharma Co Ltd is 4506.
Is 4506 the Same as $4506?
$4506 is a common way to refer to the Sumitomo Dainippon Pharma Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Sumitomo Dainippon Pharma Co Ltd Trade On?
Sumitomo Dainippon Pharma Co Ltd is listed and trades on the Tokyo stock exchange.
Is Sumitomo Dainippon Pharma Co Ltd a Good Stock to Buy?
Determining whether Sumitomo Dainippon Pharma Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Sumitomo Dainippon Pharma Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4506 quote. (ISIN: JP3495000006)
What Is the Sumitomo Dainippon Pharma Co Ltd Stock Price Today?
The Sumitomo Dainippon Pharma Co Ltd stock price today is 2,192.0.
What Is the Stock Symbol for Sumitomo Dainippon Pharma Co Ltd?
The stock ticker symbol for Sumitomo Dainippon Pharma Co Ltd is 4506.
Is 4506 the Same as $4506?
$4506 is a common way to refer to the Sumitomo Dainippon Pharma Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Sumitomo Dainippon Pharma Co Ltd Trade On?
Sumitomo Dainippon Pharma Co Ltd is listed and trades on the Tokyo stock exchange.
Is Sumitomo Dainippon Pharma Co Ltd a Good Stock to Buy?
Determining whether Sumitomo Dainippon Pharma Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Sumitomo Dainippon Pharma Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4506 quote. (ISIN: JP3495000006)
2,192.0
+157.0(+7.71%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,041.0
2,212.0
52 wk Range
506.0
3,288.0
4506 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,041.02,212.0
52 wk Range
506.03,288.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4506 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
2,223.3
Upside
+1.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Sumitomo Dainippon Pharma Co Ltd Earnings Call Summary for Q3/2026
- Sumitomo Dainippon Pharma reported Q3 2025 EPS of JPY 22.19 (vs. forecast of JPY -1.88) and revenue of JPY 120.62 billion, exceeding expectations by 17.83%, driving a 2.87% stock increase.
- Revenue grew to JPY 347.7 billion (+JPY 54.6B YoY) with core operating profit surging to JPY 109.4 billion (+JPY 87.9B YoY), primarily driven by strong North American sales performance.
- Key product performance included Orgovyx (JPY 115.6B), Myfembree (JPY 10.9B), and GEMTESA (JPY 72.3B), helping the company achieve 112.8% of its revised full-year forecast.
- Management expects normalized growth from 2026, plans 10% increase in R&D spending next fiscal year focusing on oncology and regenerative medicine, with potential approvals for Enzomenib and Nuvisertib by 2027.
- CEO Toru Kimura highlighted improved financial flexibility and strategic focus on maximizing value, while noting potential risks from Japanese drug price revisions and North American competition.
Last Updated: 02/06/2026, 09:22 AM
Read Full TranscriptSumitomo Dainippon Pharma investor slides for Q3/2026
Last Update: Feb 06, 2026
See full investor slides
Compare 4506 to Peers and Sector
Metrics to compare | 4506 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4506PeersSector | |
|---|---|---|---|---|
P/E Ratio | 7.9x | 14.9x | −0.5x | |
PEG Ratio | 0.05 | 0.05 | 0.00 | |
Price / Book | 3.0x | 1.5x | 2.6x | |
Price / LTM Sales | 1.9x | 2.1x | 3.2x | |
Upside (Analyst Target) | 2.6% | 12.8% | 47.6% | |
Fair Value Upside | Unlock | 7.8% | 6.1% | Unlock |
Analyst Ratings
3 Buy
2 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 2,223.3
(+1.43% Upside)
Earnings
Latest Release
Jan 30, 2026
EPS / Forecast
22.19 / -1.88
Revenue / Forecast
120.62B / 102.37B
People Also Watch
FAQ
What Is the Sumitomo Dainippon Pharma (4506) Stock Price Today?
The Sumitomo Dainippon Pharma stock price today is 2,192.0 JPY.
What Stock Exchange Does Sumitomo Dainippon Pharma Trade On?
Sumitomo Dainippon Pharma is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for Sumitomo Dainippon Pharma?
The stock symbol for Sumitomo Dainippon Pharma is "4506."
What Is the Sumitomo Dainippon Pharma Market Cap?
As of today, Sumitomo Dainippon Pharma market cap is 870.86B JPY.
What Is Sumitomo Dainippon Pharma's Earnings Per Share (TTM)?
The Sumitomo Dainippon Pharma EPS (TTM) is 277.1.
When Is the Next Sumitomo Dainippon Pharma Earnings Date?
Sumitomo Dainippon Pharma will release its next earnings report on May 13, 2026.
From a Technical Analysis Perspective, Is 4506 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sumitomo Dainippon Pharma Stock Split?
Sumitomo Dainippon Pharma has split 0 times.
How Many Employees Does Sumitomo Dainippon Pharma Have?
Sumitomo Dainippon Pharma has 3832 employees.
What is the current trading status of Sumitomo Dainippon Pharma (4506)?
As of Apr 15, 2026, Sumitomo Dainippon Pharma (4506) is trading at a price of 2,192.0 JPY, with a previous close of 2,192.0 JPY. The stock has fluctuated within a day range of 2,041.0 JPY to 2,212.0 JPY, while its 52-week range spans from 506.0 JPY to 3,288.0 JPY.
What Is Sumitomo Dainippon Pharma (4506) Price Target According to Analysts?
The average 12-month price target for Sumitomo Dainippon Pharma is 2,223.3 JPY, with a high estimate of 2700 JPY and a low estimate of 1640 JPY. 3 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +1.43% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.